KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.

  • Cvs Health's Shares Outstanding (Weighted Average) rose 63.54% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year increase of 63.54%. This contributed to the annual value of $1.3 billion for FY2025, which is 63.54% up from last year.
  • Per Cvs Health's latest filing, its Shares Outstanding (Weighted Average) stood at $1.3 billion for Q4 2025, which was up 63.54% from $1.3 billion recorded in Q3 2025.
  • In the past 5 years, Cvs Health's Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q3 2021 and a low of $1.3 billion during Q2 2024
  • In the last 5 years, Cvs Health's Shares Outstanding (Weighted Average) had a median value of $1.3 billion in 2023 and averaged $1.3 billion.
  • In the last 5 years, Cvs Health's Shares Outstanding (Weighted Average) skyrocketed by 83.97% in 2021 and then crashed by 228.48% in 2023.
  • Quarter analysis of 5 years shows Cvs Health's Shares Outstanding (Weighted Average) stood at $1.3 billion in 2021, then decreased by 0.53% to $1.3 billion in 2022, then fell by 2.06% to $1.3 billion in 2023, then dropped by 2.02% to $1.3 billion in 2024, then increased by 0.64% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q4 2025, $1.3 billion for Q3 2025, and $1.3 billion during Q2 2025.